Last updated on February 2010

Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation

Brief description of study

Assessing the impact of J12 curative treatment with rituximab (375 mg / m² on J5) based on a composite "TREATMENT FAILURE"

Clinical Study Identifier: NCT01066689

Find a site near you

Start Over